Igor Koturbash
Concepts (372)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epigenesis, Genetic | 28 | 2022 | 399 | 6.250 |
Why?
| DNA Methylation | 39 | 2020 | 574 | 6.240 |
Why?
| Radiation, Ionizing | 15 | 2019 | 120 | 3.990 |
Why?
| Plant Extracts | 7 | 2022 | 193 | 3.950 |
Why?
| Cannabidiol | 6 | 2020 | 35 | 3.680 |
Why?
| Methionine | 9 | 2021 | 146 | 3.420 |
Why?
| DNA Damage | 25 | 2021 | 357 | 3.260 |
Why?
| Dietary Supplements | 8 | 2022 | 449 | 3.230 |
Why?
| MicroRNAs | 12 | 2017 | 386 | 2.240 |
Why?
| Animals | 77 | 2023 | 14385 | 2.180 |
Why?
| Cannabis | 5 | 2020 | 147 | 2.090 |
Why?
| Spleen | 11 | 2016 | 186 | 2.070 |
Why?
| Mice | 50 | 2023 | 6413 | 1.960 |
Why?
| Mice, Inbred C57BL | 33 | 2020 | 1999 | 1.940 |
Why?
| Long Interspersed Nucleotide Elements | 5 | 2017 | 41 | 1.870 |
Why?
| Liver | 14 | 2022 | 1225 | 1.840 |
Why?
| Radiation Injuries | 6 | 2024 | 153 | 1.830 |
Why?
| Chromosome Aberrations | 6 | 2022 | 316 | 1.770 |
Why?
| Neoplasms | 10 | 2019 | 1315 | 1.700 |
Why?
| Space Flight | 4 | 2021 | 37 | 1.620 |
Why?
| Heart | 6 | 2023 | 360 | 1.440 |
Why?
| Bystander Effect | 6 | 2009 | 22 | 1.430 |
Why?
| Genomic Instability | 6 | 2010 | 95 | 1.340 |
Why?
| Radiation Injuries, Experimental | 3 | 2020 | 105 | 1.300 |
Why?
| Histones | 14 | 2018 | 335 | 1.190 |
Why?
| Particulate Matter | 3 | 2016 | 56 | 1.150 |
Why?
| Dose-Response Relationship, Radiation | 14 | 2023 | 204 | 1.120 |
Why?
| Iron | 4 | 2015 | 158 | 1.090 |
Why?
| Methionine Adenosyltransferase | 2 | 2018 | 20 | 1.090 |
Why?
| Repetitive Sequences, Nucleic Acid | 6 | 2019 | 92 | 1.090 |
Why?
| Melanoma | 2 | 2020 | 313 | 1.080 |
Why?
| Hematopoietic Stem Cells | 3 | 2017 | 215 | 1.080 |
Why?
| Male | 49 | 2023 | 27312 | 1.040 |
Why?
| DNA | 8 | 2024 | 581 | 1.040 |
Why?
| Gastrointestinal Tract | 3 | 2022 | 135 | 1.030 |
Why?
| Lung | 5 | 2016 | 507 | 1.030 |
Why?
| 5-Methylcytosine | 2 | 2022 | 18 | 1.020 |
Why?
| Apoptosis | 11 | 2019 | 1300 | 1.010 |
Why?
| Intestine, Small | 2 | 2020 | 123 | 0.990 |
Why?
| Tumor Suppressor Protein p53 | 5 | 2016 | 250 | 0.980 |
Why?
| Drug Approval | 2 | 2020 | 47 | 0.930 |
Why?
| Macrophages | 5 | 2021 | 405 | 0.910 |
Why?
| Disease Models, Animal | 5 | 2020 | 1639 | 0.900 |
Why?
| Astronauts | 2 | 2024 | 5 | 0.850 |
Why?
| Lymphocytes | 2 | 2022 | 168 | 0.840 |
Why?
| Rodentia | 1 | 2022 | 19 | 0.840 |
Why?
| Dose-Response Relationship, Drug | 10 | 2020 | 1476 | 0.840 |
Why?
| Tandem Mass Spectrometry | 2 | 2022 | 248 | 0.830 |
Why?
| Environmental Pollution | 1 | 2021 | 11 | 0.790 |
Why?
| Environmental Exposure | 5 | 2017 | 205 | 0.780 |
Why?
| Butadienes | 2 | 2011 | 50 | 0.770 |
Why?
| Carbon | 2 | 2019 | 61 | 0.760 |
Why?
| Cytochrome P-450 Enzyme System | 3 | 2020 | 192 | 0.760 |
Why?
| Cell Transformation, Neoplastic | 3 | 2018 | 200 | 0.740 |
Why?
| Abdomen | 1 | 2020 | 83 | 0.740 |
Why?
| Hepatocytes | 3 | 2019 | 214 | 0.730 |
Why?
| Myocardium | 3 | 2019 | 441 | 0.730 |
Why?
| Acute Radiation Syndrome | 1 | 2020 | 23 | 0.720 |
Why?
| Colitis | 1 | 2020 | 52 | 0.710 |
Why?
| Hepatic Veno-Occlusive Disease | 1 | 2019 | 10 | 0.710 |
Why?
| DNA Transposable Elements | 3 | 2015 | 82 | 0.690 |
Why?
| Anti-Obesity Agents | 1 | 2019 | 22 | 0.690 |
Why?
| Humans | 43 | 2024 | 54246 | 0.680 |
Why?
| Gene Expression | 7 | 2019 | 664 | 0.680 |
Why?
| Tea | 1 | 2019 | 35 | 0.670 |
Why?
| Cannabinoids | 1 | 2020 | 108 | 0.670 |
Why?
| Protons | 5 | 2023 | 81 | 0.670 |
Why?
| Heavy Ions | 3 | 2015 | 17 | 0.660 |
Why?
| Carcinogens, Environmental | 3 | 2015 | 36 | 0.660 |
Why?
| Cells | 1 | 2018 | 3 | 0.660 |
Why?
| Sex Characteristics | 3 | 2010 | 214 | 0.650 |
Why?
| Clofibrate | 1 | 2017 | 7 | 0.610 |
Why?
| Phenobarbital | 1 | 2017 | 17 | 0.610 |
Why?
| Carcinogens | 5 | 2012 | 231 | 0.610 |
Why?
| Oxygen | 2 | 2023 | 361 | 0.600 |
Why?
| Methylation | 5 | 2022 | 130 | 0.590 |
Why?
| Bacteria | 1 | 2019 | 258 | 0.580 |
Why?
| Epigenomics | 5 | 2017 | 67 | 0.560 |
Why?
| Oxidative Stress | 5 | 2017 | 958 | 0.550 |
Why?
| Acetaminophen | 1 | 2019 | 349 | 0.540 |
Why?
| Pharmacogenetics | 1 | 2015 | 55 | 0.530 |
Why?
| Safety | 1 | 2015 | 92 | 0.520 |
Why?
| Liver Neoplasms, Experimental | 2 | 2013 | 48 | 0.520 |
Why?
| DNA, Neoplasm | 1 | 2015 | 171 | 0.510 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 866 | 0.500 |
Why?
| Environmental Pollutants | 1 | 2015 | 101 | 0.490 |
Why?
| Toxicity Tests | 3 | 2020 | 52 | 0.470 |
Why?
| Obesity | 3 | 2019 | 1197 | 0.470 |
Why?
| Whole-Body Irradiation | 6 | 2020 | 160 | 0.460 |
Why?
| Lysine | 3 | 2013 | 102 | 0.440 |
Why?
| Cell Proliferation | 8 | 2011 | 1096 | 0.430 |
Why?
| Vitamins | 2 | 2022 | 72 | 0.430 |
Why?
| Xenobiotics | 1 | 2012 | 27 | 0.420 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2012 | 29 | 0.420 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2011 | 53 | 0.410 |
Why?
| Cosmic Radiation | 4 | 2023 | 38 | 0.410 |
Why?
| DNA Adducts | 3 | 2012 | 162 | 0.410 |
Why?
| Mice, Inbred CBA | 4 | 2021 | 39 | 0.410 |
Why?
| Cranial Irradiation | 2 | 2008 | 24 | 0.400 |
Why?
| Female | 23 | 2022 | 28418 | 0.390 |
Why?
| Paternal Exposure | 2 | 2009 | 6 | 0.390 |
Why?
| Frontal Lobe | 1 | 2010 | 56 | 0.370 |
Why?
| Neoplasm Metastasis | 3 | 2018 | 252 | 0.370 |
Why?
| United States Food and Drug Administration | 2 | 2020 | 97 | 0.370 |
Why?
| DNA Repair | 6 | 2021 | 202 | 0.370 |
Why?
| Maternal Exposure | 2 | 2009 | 87 | 0.360 |
Why?
| Escherichia coli O157 | 1 | 2009 | 12 | 0.350 |
Why?
| Antineoplastic Agents | 1 | 2018 | 1300 | 0.350 |
Why?
| Gene Expression Profiling | 4 | 2019 | 1138 | 0.350 |
Why?
| Nanoparticles | 3 | 2015 | 173 | 0.350 |
Why?
| Inflammation | 1 | 2014 | 674 | 0.350 |
Why?
| Mice, Inbred Strains | 3 | 2019 | 198 | 0.350 |
Why?
| Cerebellum | 1 | 2010 | 142 | 0.340 |
Why?
| Rats | 11 | 2023 | 3415 | 0.340 |
Why?
| Neoplasms, Radiation-Induced | 3 | 2016 | 42 | 0.340 |
Why?
| RNA-Induced Silencing Complex | 1 | 2008 | 2 | 0.330 |
Why?
| Transcriptome | 3 | 2020 | 346 | 0.320 |
Why?
| Reactive Oxygen Species | 3 | 2015 | 491 | 0.320 |
Why?
| Hippocampus | 1 | 2010 | 242 | 0.320 |
Why?
| DNA, Satellite | 2 | 2019 | 15 | 0.310 |
Why?
| Chemokines | 2 | 2020 | 96 | 0.310 |
Why?
| Thymus Gland | 5 | 2008 | 45 | 0.310 |
Why?
| Radiation Dosage | 5 | 2020 | 170 | 0.300 |
Why?
| Escherichia coli | 1 | 2009 | 250 | 0.300 |
Why?
| Energy Metabolism | 2 | 2020 | 311 | 0.290 |
Why?
| Arkansas | 2 | 2022 | 2094 | 0.280 |
Why?
| Radiation | 1 | 2005 | 17 | 0.270 |
Why?
| Mammary Glands, Animal | 4 | 2015 | 69 | 0.240 |
Why?
| Body Weight | 2 | 2020 | 578 | 0.240 |
Why?
| Risk Assessment | 4 | 2019 | 1361 | 0.240 |
Why?
| Chromatography, Liquid | 2 | 2022 | 243 | 0.240 |
Why?
| Ions | 2 | 2023 | 38 | 0.230 |
Why?
| Time Factors | 5 | 2015 | 3212 | 0.230 |
Why?
| Plant Preparations | 1 | 2022 | 38 | 0.220 |
Why?
| Cytogenetic Analysis | 1 | 2022 | 90 | 0.220 |
Why?
| Bone Marrow Cells | 2 | 2021 | 233 | 0.220 |
Why?
| Blotting, Western | 4 | 2011 | 683 | 0.210 |
Why?
| Precancerous Conditions | 3 | 2013 | 93 | 0.210 |
Why?
| Linear Energy Transfer | 3 | 2017 | 17 | 0.210 |
Why?
| Permeability | 1 | 2022 | 87 | 0.210 |
Why?
| 2-Acetylaminofluorene | 2 | 2011 | 30 | 0.210 |
Why?
| Metabolic Networks and Pathways | 2 | 2019 | 104 | 0.200 |
Why?
| Drug Resistance, Neoplasm | 2 | 2015 | 309 | 0.200 |
Why?
| Gene Expression Regulation | 3 | 2017 | 1062 | 0.200 |
Why?
| Taurine | 1 | 2020 | 16 | 0.200 |
Why?
| Herb-Drug Interactions | 1 | 2020 | 30 | 0.190 |
Why?
| Diet | 3 | 2021 | 597 | 0.190 |
Why?
| Mucin-2 | 1 | 2020 | 9 | 0.190 |
Why?
| Alkaline Phosphatase | 1 | 2020 | 99 | 0.190 |
Why?
| Intestines | 1 | 2022 | 204 | 0.180 |
Why?
| Gamma Rays | 2 | 2017 | 56 | 0.180 |
Why?
| X-Rays | 5 | 2010 | 57 | 0.180 |
Why?
| Administration, Oral | 2 | 2018 | 459 | 0.180 |
Why?
| Malnutrition | 1 | 2021 | 83 | 0.180 |
Why?
| Cell Line | 5 | 2015 | 1153 | 0.180 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 673 | 0.180 |
Why?
| Colon | 1 | 2020 | 110 | 0.180 |
Why?
| Centromere | 1 | 2019 | 17 | 0.180 |
Why?
| Glutamine | 1 | 2020 | 168 | 0.180 |
Why?
| Liver Function Tests | 1 | 2019 | 43 | 0.170 |
Why?
| Germ Cells | 2 | 2009 | 14 | 0.170 |
Why?
| Tight Junctions | 1 | 2019 | 28 | 0.170 |
Why?
| Oxygen Radioisotopes | 1 | 2019 | 16 | 0.170 |
Why?
| Cytokines | 2 | 2020 | 676 | 0.170 |
Why?
| Thinness | 1 | 2019 | 57 | 0.170 |
Why?
| Drug Synergism | 1 | 2019 | 171 | 0.170 |
Why?
| Down-Regulation | 2 | 2011 | 388 | 0.170 |
Why?
| Copper | 2 | 2015 | 48 | 0.170 |
Why?
| Intestinal Mucosa | 1 | 2020 | 259 | 0.160 |
Why?
| Models, Genetic | 2 | 2017 | 209 | 0.160 |
Why?
| Animals, Outbred Strains | 1 | 2017 | 13 | 0.160 |
Why?
| Acetylation | 3 | 2013 | 99 | 0.160 |
Why?
| Retroelements | 1 | 2017 | 15 | 0.150 |
Why?
| Gene-Environment Interaction | 1 | 2017 | 44 | 0.150 |
Why?
| Metagenome | 1 | 2017 | 44 | 0.150 |
Why?
| Weightlessness Simulation | 1 | 2017 | 23 | 0.150 |
Why?
| Pandemics | 1 | 2022 | 579 | 0.150 |
Why?
| Spectral Karyotyping | 1 | 2017 | 8 | 0.150 |
Why?
| Aging | 2 | 2014 | 784 | 0.150 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2018 | 377 | 0.150 |
Why?
| Hematopoiesis | 1 | 2017 | 80 | 0.150 |
Why?
| Species Specificity | 1 | 2017 | 205 | 0.150 |
Why?
| Organ Size | 1 | 2017 | 237 | 0.150 |
Why?
| Brain | 3 | 2019 | 1387 | 0.150 |
Why?
| Drug Evaluation, Preclinical | 1 | 2017 | 158 | 0.150 |
Why?
| Metabolomics | 1 | 2018 | 149 | 0.150 |
Why?
| Molecular Targeted Therapy | 1 | 2018 | 128 | 0.150 |
Why?
| Radioactive Hazard Release | 1 | 2016 | 16 | 0.150 |
Why?
| Rats, Inbred F344 | 1 | 2017 | 209 | 0.150 |
Why?
| Survival Analysis | 1 | 2019 | 735 | 0.150 |
Why?
| RNA, Messenger | 1 | 2020 | 1202 | 0.150 |
Why?
| Feeding Behavior | 1 | 2018 | 199 | 0.140 |
Why?
| Azacitidine | 1 | 2016 | 37 | 0.140 |
Why?
| Metabolome | 1 | 2017 | 109 | 0.140 |
Why?
| Cell Culture Techniques | 1 | 2016 | 112 | 0.140 |
Why?
| Cells, Cultured | 3 | 2016 | 1737 | 0.140 |
Why?
| Cell Line, Tumor | 2 | 2018 | 1550 | 0.140 |
Why?
| Mutation | 4 | 2018 | 1501 | 0.140 |
Why?
| Tocotrienols | 1 | 2016 | 42 | 0.140 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2017 | 278 | 0.140 |
Why?
| DNA-Binding Proteins | 2 | 2009 | 462 | 0.140 |
Why?
| Interleukin-13 | 1 | 2015 | 16 | 0.140 |
Why?
| Blood Glucose | 1 | 2019 | 488 | 0.140 |
Why?
| Echocardiography | 1 | 2018 | 392 | 0.130 |
Why?
| Cytotoxins | 1 | 2015 | 17 | 0.130 |
Why?
| Macrophages, Alveolar | 1 | 2015 | 26 | 0.130 |
Why?
| Radiotherapy | 1 | 2016 | 138 | 0.130 |
Why?
| Hazardous Substances | 1 | 2015 | 16 | 0.130 |
Why?
| Methyltransferases | 2 | 2015 | 28 | 0.130 |
Why?
| Radiography | 1 | 2016 | 524 | 0.130 |
Why?
| Genetic Markers | 2 | 2015 | 117 | 0.130 |
Why?
| Vitamin E | 1 | 2016 | 107 | 0.130 |
Why?
| Sequence Analysis, DNA | 1 | 2016 | 273 | 0.130 |
Why?
| Uterus | 1 | 2015 | 98 | 0.120 |
Why?
| Benzhydryl Compounds | 1 | 2015 | 75 | 0.120 |
Why?
| Prostate | 1 | 2015 | 117 | 0.120 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 295 | 0.120 |
Why?
| Gene Dosage | 1 | 2014 | 91 | 0.120 |
Why?
| Pulmonary Fibrosis | 1 | 2014 | 20 | 0.120 |
Why?
| In Situ Nick-End Labeling | 1 | 2014 | 64 | 0.120 |
Why?
| L-Lactate Dehydrogenase | 1 | 2014 | 79 | 0.120 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 206 | 0.120 |
Why?
| Rats, Sprague-Dawley | 3 | 2015 | 1663 | 0.120 |
Why?
| Random Allocation | 3 | 2013 | 312 | 0.120 |
Why?
| Lung Injury | 1 | 2014 | 25 | 0.120 |
Why?
| Phenols | 1 | 2015 | 120 | 0.120 |
Why?
| Risk Factors | 2 | 2020 | 3930 | 0.120 |
Why?
| Butyric Acid | 1 | 2013 | 10 | 0.110 |
Why?
| Rats, Long-Evans | 3 | 2008 | 29 | 0.110 |
Why?
| Prodrugs | 1 | 2013 | 33 | 0.110 |
Why?
| Heart Diseases | 1 | 2016 | 237 | 0.110 |
Why?
| Radiation Protection | 2 | 2016 | 55 | 0.110 |
Why?
| Organ Specificity | 2 | 2010 | 126 | 0.110 |
Why?
| Choline Deficiency | 1 | 2012 | 23 | 0.110 |
Why?
| Choline | 1 | 2012 | 63 | 0.110 |
Why?
| Folic Acid Deficiency | 1 | 2012 | 43 | 0.110 |
Why?
| Acrylamide | 1 | 2012 | 7 | 0.110 |
Why?
| United States | 2 | 2020 | 5200 | 0.110 |
Why?
| Genes, ras | 1 | 2012 | 48 | 0.110 |
Why?
| Mice, Inbred BALB C | 2 | 2015 | 368 | 0.110 |
Why?
| S-Adenosylhomocysteine | 1 | 2011 | 41 | 0.110 |
Why?
| Epoxy Compounds | 1 | 2012 | 48 | 0.100 |
Why?
| S-Adenosylmethionine | 1 | 2011 | 56 | 0.100 |
Why?
| Triglycerides | 1 | 2013 | 195 | 0.100 |
Why?
| Models, Animal | 2 | 2016 | 255 | 0.100 |
Why?
| Epithelial Cells | 4 | 2015 | 255 | 0.100 |
Why?
| Polymerase Chain Reaction | 2 | 2010 | 531 | 0.100 |
Why?
| Cell Differentiation | 1 | 2015 | 720 | 0.100 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 434 | 0.100 |
Why?
| Estrogens | 2 | 2010 | 244 | 0.100 |
Why?
| Biological Transport | 1 | 2012 | 195 | 0.100 |
Why?
| Folic Acid | 1 | 2012 | 139 | 0.100 |
Why?
| Testis | 2 | 2008 | 65 | 0.100 |
Why?
| Immunohistochemistry | 3 | 2010 | 1089 | 0.100 |
Why?
| Environment | 1 | 2012 | 103 | 0.100 |
Why?
| Guanine | 1 | 2011 | 42 | 0.100 |
Why?
| Mice, Inbred NOD | 1 | 2011 | 99 | 0.100 |
Why?
| Inhalation | 1 | 2010 | 6 | 0.100 |
Why?
| Fatty Liver | 1 | 2012 | 129 | 0.100 |
Why?
| Lipid Metabolism | 1 | 2012 | 194 | 0.100 |
Why?
| Histone Demethylases | 1 | 2010 | 15 | 0.100 |
Why?
| Up-Regulation | 2 | 2013 | 508 | 0.100 |
Why?
| Liver Neoplasms | 2 | 2012 | 352 | 0.090 |
Why?
| Mammary Neoplasms, Animal | 1 | 2010 | 38 | 0.090 |
Why?
| Oncogenes | 1 | 2010 | 63 | 0.090 |
Why?
| Genes, Tumor Suppressor | 1 | 2010 | 85 | 0.090 |
Why?
| Antigens, Nuclear | 1 | 2009 | 24 | 0.090 |
Why?
| Repressor Proteins | 1 | 2010 | 165 | 0.090 |
Why?
| Neoplastic Stem Cells | 1 | 2010 | 103 | 0.090 |
Why?
| Promoter Regions, Genetic | 1 | 2011 | 520 | 0.090 |
Why?
| Lymphopoiesis | 1 | 2008 | 2 | 0.080 |
Why?
| Muscles | 1 | 2009 | 114 | 0.080 |
Why?
| Methyl-CpG-Binding Protein 2 | 1 | 2008 | 12 | 0.080 |
Why?
| Castration | 1 | 2008 | 5 | 0.080 |
Why?
| Ribonuclease III | 1 | 2008 | 12 | 0.080 |
Why?
| Endoribonucleases | 1 | 2008 | 15 | 0.080 |
Why?
| Abnormalities, Radiation-Induced | 1 | 2008 | 8 | 0.080 |
Why?
| Microarray Analysis | 1 | 2008 | 84 | 0.080 |
Why?
| DEAD-box RNA Helicases | 1 | 2008 | 35 | 0.080 |
Why?
| Ovariectomy | 1 | 2008 | 125 | 0.080 |
Why?
| Germ-Line Mutation | 1 | 2008 | 68 | 0.080 |
Why?
| Lung Neoplasms | 1 | 2014 | 642 | 0.080 |
Why?
| Alpha Particles | 1 | 2007 | 1 | 0.080 |
Why?
| Radiation Tolerance | 1 | 2008 | 86 | 0.080 |
Why?
| Air Pollutants | 1 | 2008 | 70 | 0.080 |
Why?
| Cytosine | 1 | 2006 | 29 | 0.070 |
Why?
| Parents | 1 | 2009 | 344 | 0.070 |
Why?
| Mammary Neoplasms, Experimental | 1 | 2006 | 135 | 0.070 |
Why?
| Skin | 1 | 2009 | 469 | 0.070 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 151 | 0.060 |
Why?
| Lymphoma | 1 | 2005 | 72 | 0.060 |
Why?
| Antioxidants | 2 | 2017 | 297 | 0.060 |
Why?
| Cell Cycle Proteins | 1 | 2005 | 199 | 0.060 |
Why?
| Cellular Microenvironment | 1 | 2024 | 27 | 0.060 |
Why?
| DNA Breaks, Double-Stranded | 2 | 2016 | 78 | 0.060 |
Why?
| Neoplasm Proteins | 1 | 2005 | 359 | 0.060 |
Why?
| Rabbits | 1 | 2023 | 425 | 0.050 |
Why?
| Sex Factors | 3 | 2008 | 765 | 0.050 |
Why?
| Disease Progression | 2 | 2015 | 913 | 0.050 |
Why?
| Monocytes | 1 | 2021 | 156 | 0.050 |
Why?
| Carbohydrate Metabolism | 1 | 2017 | 31 | 0.040 |
Why?
| Enzymes | 1 | 2017 | 31 | 0.040 |
Why?
| Chromosome Painting | 1 | 2017 | 9 | 0.040 |
Why?
| DNA Probes | 1 | 2017 | 27 | 0.040 |
Why?
| Body Burden | 1 | 2016 | 12 | 0.040 |
Why?
| Metaphase | 1 | 2016 | 55 | 0.040 |
Why?
| Phosphorylation | 2 | 2011 | 614 | 0.040 |
Why?
| Lipopolysaccharides | 1 | 2017 | 199 | 0.040 |
Why?
| Fluorescent Dyes | 1 | 2017 | 116 | 0.040 |
Why?
| Solar Activity | 1 | 2015 | 8 | 0.030 |
Why?
| DNA Repair Enzymes | 1 | 2016 | 50 | 0.030 |
Why?
| Collagen | 1 | 2017 | 223 | 0.030 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 95 | 0.030 |
Why?
| Printing | 1 | 2015 | 4 | 0.030 |
Why?
| Welding | 1 | 2015 | 4 | 0.030 |
Why?
| Steel | 1 | 2015 | 5 | 0.030 |
Why?
| Endpoint Determination | 1 | 2015 | 30 | 0.030 |
Why?
| Ethinyl Estradiol | 1 | 2015 | 8 | 0.030 |
Why?
| Inhalation Exposure | 1 | 2015 | 34 | 0.030 |
Why?
| Complement C3 | 1 | 2015 | 31 | 0.030 |
Why?
| Titanium | 1 | 2015 | 53 | 0.030 |
Why?
| Receptors, Progesterone | 1 | 2015 | 57 | 0.030 |
Why?
| DNA End-Joining Repair | 1 | 2014 | 14 | 0.030 |
Why?
| Environmental Monitoring | 1 | 2015 | 71 | 0.030 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2015 | 53 | 0.030 |
Why?
| Translocation, Genetic | 1 | 2017 | 287 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 151 | 0.030 |
Why?
| Homologous Recombination | 1 | 2014 | 43 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 2015 | 131 | 0.030 |
Why?
| Infant | 1 | 2023 | 3817 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2015 | 230 | 0.030 |
Why?
| Stem Cells | 1 | 2015 | 193 | 0.030 |
Why?
| DNA-Directed DNA Polymerase | 1 | 2014 | 96 | 0.030 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2015 | 173 | 0.030 |
Why?
| Cell Survival | 1 | 2015 | 657 | 0.030 |
Why?
| Genomics | 1 | 2015 | 310 | 0.030 |
Why?
| Protein Binding | 1 | 2015 | 736 | 0.030 |
Why?
| Histone Deacetylases | 1 | 2013 | 47 | 0.030 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2013 | 56 | 0.030 |
Why?
| Protein Array Analysis | 1 | 2012 | 28 | 0.030 |
Why?
| Flow Cytometry | 1 | 2015 | 546 | 0.030 |
Why?
| Rats, Wistar | 1 | 2013 | 237 | 0.030 |
Why?
| Signal Transduction | 2 | 2013 | 1753 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2015 | 746 | 0.030 |
Why?
| Adenoma, Liver Cell | 1 | 2012 | 9 | 0.030 |
Why?
| Animal Feed | 1 | 2012 | 64 | 0.030 |
Why?
| Carcinogenicity Tests | 1 | 2012 | 32 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 2012 | 82 | 0.030 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2011 | 31 | 0.030 |
Why?
| Cation Transport Proteins | 1 | 2011 | 28 | 0.030 |
Why?
| Child | 2 | 2016 | 7337 | 0.030 |
Why?
| Genetic Variation | 1 | 2012 | 253 | 0.020 |
Why?
| Animals, Newborn | 1 | 2012 | 396 | 0.020 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 14 | 0.020 |
Why?
| Genes, p53 | 1 | 2010 | 60 | 0.020 |
Why?
| Homeostasis | 1 | 2011 | 223 | 0.020 |
Why?
| NIH 3T3 Cells | 1 | 2009 | 55 | 0.020 |
Why?
| Spermatocytes | 1 | 2008 | 3 | 0.020 |
Why?
| Industry | 1 | 2008 | 19 | 0.020 |
Why?
| Spermatozoa | 1 | 2008 | 28 | 0.020 |
Why?
| Age Factors | 1 | 2011 | 1195 | 0.020 |
Why?
| Air Pollution | 1 | 2008 | 45 | 0.020 |
Why?
| Pregnancy | 1 | 2015 | 2620 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2008 | 217 | 0.020 |
Why?
| Tissue Culture Techniques | 1 | 2007 | 46 | 0.020 |
Why?
| Bronchi | 1 | 2007 | 51 | 0.020 |
Why?
| Rad51 Recombinase | 1 | 2006 | 21 | 0.020 |
Why?
| Trachea | 1 | 2007 | 51 | 0.020 |
Why?
| Keratinocytes | 1 | 2007 | 96 | 0.020 |
Why?
| Serine Proteases | 1 | 2005 | 3 | 0.020 |
Why?
| Retinoblastoma Protein | 1 | 2005 | 21 | 0.020 |
Why?
| Bone Marrow | 1 | 2008 | 411 | 0.020 |
Why?
|
|
Koturbash's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|